Transplant Genomics
Total Raised
$20.61MInvestors Count
2Deal Terms
2Funding, Valuation & Revenue
9 Fundings
Transplant Genomics has raised $20.61M over 9 rounds.
Transplant Genomics's latest funding round was a Acquired for on June 25, 2019.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/25/2019 | Acquired | 2 | ||||
9/6/2018 | Series B | |||||
4/5/2017 | Series A | |||||
1/7/2017 | Debt - IV | |||||
5/9/2016 | Debt - III |
Date | 6/25/2019 | 9/6/2018 | 4/5/2017 | 1/7/2017 | 5/9/2016 |
|---|---|---|---|---|---|
Round | Acquired | Series B | Series A | Debt - IV | Debt - III |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 |
Transplant Genomics Deal Terms
2 Deal Terms
Transplant Genomics's deal structure is available for 2 funding rounds, including their Series B from September 06, 2018.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Transplant Genomics Investors
2 Investors
Transplant Genomics has 2 investors. Eurofins Scientific invested in Transplant Genomics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/25/2019 | 6/25/2019 | 1 Acquired | Corporation | Luxembourg | ||
Venture Capital | Massachusetts |
First funding | 6/25/2019 | |
|---|---|---|
Last Funding | 6/25/2019 | |
Investor | ||
Rounds | 1 Acquired | |
Board Seats | ||
Type | Corporation | Venture Capital |
Location | Luxembourg | Massachusetts |
Loading...